Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enchondroma
|
13 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Hemangioma
|
24 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Vascular lesions
|
9 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Childhood Gliomatosis Cerebri
|
6 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Gliomatosis cerebri
|
6 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant Neoplasms
|
1641 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||
Primary malignant neoplasm
|
1374 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA
|
19 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Carcinogenesis
|
355 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Adult Oligodendroglioma
|
19 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.030 | 1.000 | 3 | 2013 | 2016 | ||||
Childhood Oligodendroglioma
|
19 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.030 | 1.000 | 3 | 2013 | 2016 | ||||
Anaplastic Oligoastrocytoma
|
4 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||
Childhood Anaplastic Oligoastrocytoma
|
4 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||
Adult Anaplastic Oligodendroglioma
|
4 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Anaplastic Oligodendroglioma
|
7 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Carcinoma of lung
|
1204 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1 | 2016 | 2016 | |||||
Childhood Anaplastic Oligodendroglioma
|
4 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Malignant neoplasm of lung
|
1142 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1 | 2016 | 2016 | |||||
Primary malignant neoplasm of lung
|
981 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.010 | 1 | 2016 | 2016 | |||||
oligodendroglioma
|
21 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.060 | 1.000 | 6 | 2013 | 2017 | ||||
Well Differentiated Oligodendroglioma
|
22 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.060 | 1.000 | 6 | 2013 | 2017 | ||||
Adult Glioblastoma
|
98 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.050 | 0.800 | 5 | 2013 | 2017 | ||||
Childhood Glioblastoma
|
98 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.050 | 0.800 | 5 | 2013 | 2017 | ||||
Adult Anaplastic Astrocytoma
|
8 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||
Brain Neoplasms
|
204 | 0.614 | 0.280 | 15 | 90087472 | missense variant | C/T | snv | 2.0E-03 | 1.6E-03 | 0.020 | 1.000 | 2 | 2011 | 2017 |